Valeritas Holdings Inc (NASDAQ:VLRX)’s stock price was down 5.2% on Friday . The company traded as low as $3.02 and last traded at $2.93, approximately 8,905 shares changed hands during trading. A decline of 99% from the average daily volume of 698,629 shares. The stock had previously closed at $3.09.
A number of analysts have weighed in on VLRX shares. ValuEngine cut shares of Zumiez from a “hold” rating to a “sell” rating in a report on Tuesday, July 2nd. Oppenheimer increased their target price on shares of Valeritas from $1.25 to $12.00 and gave the stock an “outperform” rating in a report on Tuesday, July 9th. Finally, Zacks Investment Research raised shares of Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Saturday.
The firm has a 50-day moving average price of $3.02. The company has a current ratio of 3.32, a quick ratio of 2.81 and a debt-to-equity ratio of 29.19.
Valeritas (NASDAQ:VLRX) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.15) EPS for the quarter, hitting the consensus estimate of ($0.15). The business had revenue of $6.40 million during the quarter, compared to analyst estimates of $6.20 million. Valeritas had a negative net margin of 183.53% and a negative return on equity of 1,757.04%. Sell-side analysts forecast that Valeritas Holdings Inc will post -11.14 earnings per share for the current fiscal year.
In other news, major shareholder Armistice Capital Master Fund purchased 24,000 shares of the stock in a transaction dated Friday, May 24th. The stock was acquired at an average price of $2.27 per share, for a total transaction of $54,480.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have bought 350,000 shares of company stock valued at $234,640 in the last 90 days. Insiders own 1.02% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in shares of Valeritas by 138.0% during the fourth quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock worth $60,000 after acquiring an additional 108,416 shares during the last quarter. Weiss Multi Strategy Advisers LLC bought a new position in Valeritas in the 4th quarter valued at about $41,000. Northern Trust Corp grew its position in Valeritas by 855.4% in the 4th quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock valued at $60,000 after buying an additional 166,057 shares in the last quarter. Millennium Management LLC bought a new position in Valeritas in the 4th quarter valued at about $165,000. Finally, CVI Holdings LLC bought a new position in Valeritas in the 4th quarter valued at about $832,000.
Valeritas Company Profile (NASDAQ:VLRX)
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization.
Read More: Cash Asset Ratio
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.